Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.49 |
| ▸ | LPL | P06858 | 7/20 | 0.49 |
| ▸ | CA1 | P00915 | 9/20 | 0.45 |
| ▸ | CA2 | P00918 | 9/20 | 0.45 |
| ▸ | CA9 | Q16790 | 8/20 | 0.45 |
| ▸ | P4HB | P07237 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16968584 | 0.94 | LIPG (0.56) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL105161 | 0.92 | CA1 (0.50) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL19861978 | 0.86 | CA1 (0.41) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL2187091 | 0.85 | CA1 (0.49) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL23518587 | 0.84 | RAB9A (0.56) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL19459296 | 0.84 | PTPN11 (0.49) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL15897022 | 0.82 | LIPG (0.57) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL9985664 | 0.82 | CA1 (0.54) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL6622392 | 0.81 | SLC6A3 (0.41) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL17129341 | 0.79 | RAB9A (0.59) | CA1CA2CA9DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454034-B2 | Hexabenzocoronene-based compound for organic photovoltaic cells | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-10-22 | — | — | US | disclosed |
| US-20180047906-A1 | HEXABENZOCORONENE-BASED COMPOUND FOR ORGANIC PHOTOVOLTAIC CELLS | UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR (FR) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10454034-B2 | Hexabenzocoronene-based compound for organic photovoltaic cells | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PPOX, PAX3 | LIPG 4063/4885LPL 4064/4885CA1 3208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.